Patrick Kasl

Mr. Patrick Kasl

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 February 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
AMAshley Mason
Ashley Mason
PKPatrick Kasl
Patrick Kasl
WHWendy Hartogensis
Wendy Hartogensis
JNJoseph L. Natale
Joseph L. Natale
SDStephan Dilchert
Stephan Dilchert
FHFrederick M. Hecht
Frederick M. Hecht
There is significant variability in neutralizing antibody responses (which correlate with immune protection) after COVID-19 vaccination, but only limited information is available about predictors of these responses. We investigated whether device-generated summaries of physiological metrics collected by a wearable device correlated with post-vaccination levels of antibodies to the SARS-CoV-2 receptor-binding domain (RBD), the target of neutralizing antibodies generated by existing COVID-19 vaccines. One thousand, one hundred and seventy-nine participants wore an off-the-shelf wearable device (Oura Ring), reported dates of COVID-19 vaccinations, and completed testing for antibodies to the SARS-CoV-2 RBD during the U.S. COVID-19 vaccination rollout. We found that on the night immediately following the second mRNA injection (Moderna-NIAID and Pfizer-BioNTech) increases in dermal temperature deviation and resting heart rate, and decreases in heart rate variability (a measure of sympathetic nervous system activation) and deep sleep were each statistically significantly correlated with greater RBD antibody responses. These associations were stronger in models using metrics adjusted for the pre-vaccination baseline period. Greater temperature deviation emerged as the strongest independent predictor of greater RBD antibody responses in multivariable models. In contrast to data on certain other vaccines, we did not find clear associations between increased sleep surrounding vaccination and antibody responses.

12 March 2024 in Sensors
Verified
Journal Article
Open access
PDF file
PKPatrick Kasl
Patrick Kasl
LBLauryn Keeler Bruce
Lauryn Keeler Bruce
WHWendy Hartogensis
Wendy Hartogensis
Subhasis DasguptaSubhasis Dasgupta
Subhasis Dasgupta
LPLeena S. Pandya
Leena S. Pandya
BSBenjamin Smarr
Benjamin Smarr
Commercially available wearable devices (wearables) show promise for continuous physiological monitoring. Previous works have demonstrated that wearables can be used to detect the onset of acute infectious diseases, particularly those characterized by fever. We aimed to evaluate whether these devices could be used for the more general task of syndromic surveillance. We obtained wearable device data (Oura Ring) from 63,153 participants. We constructed a dataset using participants’ wearable device data and participants’ responses to daily online questionnaires. We included days from the participants if they (1) completed the questionnaire, (2) reported not experiencing fever and reported a self-collected body temperature below 38 °C (negative class), or reported experiencing fever and reported a self-collected body temperature at or above 38 °C (positive class), and (3) wore the wearable device the nights before and after that day. We used wearable device data (i.e., skin temperature, heart rate, and sleep) from the nights before and after participants’ fever day to train a tree-based classifier to detect self-reported fevers. We evaluated the performance of our model using a five-fold cross-validation scheme. Sixteen thousand, seven hundred, and ninety-four participants provided at least one valid ground truth day; there were a total of 724 fever days (positive class examples) from 463 participants and 342,430 non-fever days (negative class examples) from 16,687 participants. Our model exhibited an area under the receiver operating characteristic curve (AUROC) of 0.85 and an average precision (AP) of 0.25. At a sensitivity of 0.50, our calibrated model had a false positive rate of 0.8%. Our results suggest that it might be possible to leverage data from these devices at a public health level for live fever surveillance. Implementing these models could increase our ability to detect disease prevalence and spread in real-time during infectious disease outbreaks.

21 May 2025 in Journal of Medical Internet Research
Verified
Journal Article
Open access
SSSeverine Soltani
Severine Soltani
VVVarun K Viswanath
Varun K Viswanath
PKPatrick Kasl
Patrick Kasl
WHWendy Hartogensis
Wendy Hartogensis
SDStephan Dilchert
Stephan Dilchert
BSBenjamin Smarr
Benjamin Smarr
Background: The recent emergence of wearable devices has made feasible the passive gathering of intensive, longitudinal data from large groups of individuals. This form of data is effective at capturing physiological changes between participants (interindividual variability) and changes within participants over time (intraindividual variability). The emergence of longitudinal datasets provides an opportunity to quantify the contribution of such longitudinal data to the control of these sources of variability for applications such as responder analysis, where traditional, sparser sampling methods may hinder the categorization of individuals into these phenotypes. Objective: This study aimed to quantify the gains made in statistical power and effect size among statistical comparisons when controlling for interindividual variability and intraindividual variability compared with controlling for neither. Methods: Here, we test the gains in statistical power from controlling for interindividual and intraindividual variability of resting heart rate, collected in 2020 for over 40,000 individuals as part of the TemPredict study on COVID-19 detection. We compared heart rate on weekends with that on weekdays because weekends predictably change the behavior of most individuals, though not all, and in different ways. Weekends also repeat consistently, making their effects on heart rate feasible to assess with confidence over large populations. We therefore used weekends as a model system to test the impact of different statistical controls on detecting a recurring event with a clear ground truth. We randomly and iteratively sampled heart rate from weekday and weekend nights, controlling for interindividual variability, intraindividual variability, both, or neither. Results: Between-participant variability appeared to be a greater source of structured variability than within-participant fluctuations. Accounting for interindividual variability through within-individual sampling required 40× fewer pairs of samples to achieve statistical significance with 4× to 5× greater effect size at significance. Within-individual sampling revealed differential effects of weekends on heart rate, which were obscured by aggregated sampling methods. Conclusions: This work highlights the leverage provided by longitudinal, within-individual sampling to increase statistical power among populations with heterogeneous effects.

29 May 2024 in JMIR Preprints
Verified
Preprint
Open access
SSSeverine Soltani
Severine Soltani
VVVarun K Viswanath
Varun K Viswanath
PKPatrick Kasl
Patrick Kasl
WHWendy Hartogensis
Wendy Hartogensis
SDStephan Dilchert
Stephan Dilchert
BSBenjamin Smarr
Benjamin Smarr
BACKGROUND The recent emergence of wearable devices has made feasible the passive gathering of intensive, longitudinal data from large groups of individuals. This form of data is effective at capturing physiological changes between participants (interindividual variability) and changes within participants over time (intraindividual variability). The emergence of longitudinal datasets provides an opportunity to quantify the contribution of such longitudinal data to the control of these sources of variability for applications such as responder analysis, where traditional, sparser sampling methods may hinder the categorization of individuals into these phenotypes. OBJECTIVE This study aimed to quantify the gains made in statistical power and effect size among statistical comparisons when controlling for interindividual variability and intraindividual variability compared with controlling for neither. METHODS Here, we test the gains in statistical power from controlling for interindividual and intraindividual variability of resting heart rate, collected in 2020 for over 40,000 individuals as part of the TemPredict study on COVID-19 detection. We compared heart rate on weekends with that on weekdays because weekends predictably change the behavior of most individuals, though not all, and in different ways. Weekends also repeat consistently, making their effects on heart rate feasible to assess with confidence over large populations. We therefore used weekends as a model system to test the impact of different statistical controls on detecting a recurring event with a clear ground truth. We randomly and iteratively sampled heart rate from weekday and weekend nights, controlling for interindividual variability, intraindividual variability, both, or neither. RESULTS Between-participant variability appeared to be a greater source of structured variability than within-participant fluctuations. Accounting for interindividual variability through within-individual sampling required 40× fewer pairs of samples to achieve statistical significance with 4× to 5× greater effect size at significance. Within-individual sampling revealed differential effects of weekends on heart rate, which were obscured by aggregated sampling methods. CONCLUSIONS This work highlights the leverage provided by longitudinal, within-individual sampling to increase statistical power among populations with heterogeneous effects. CLINICALTRIAL